Crinetics terminates ATM sales agreement effective Vertex merger closing
Crinetics Pharmaceuticals terminated its at-the-market equity Sales Agreement with SVB Leerink and Cantor Fitzgerald, effective at the merger closing with Vertex. The agreement was dated June 21, 2024.
Crinetics Pharmaceuticals terminated its at-the-market equity Sales Agreement with SVB Leerink and Cantor Fitzgerald, effective at the merger closing with Vertex.
The agreement, originally dated June 21, 2024, was ended as trading in Crinetics shares was suspended and the stock will be delisted fro…